n.moreau
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 5 February 2025 · last posted 1d
73Posts here
0Topics
1Solutions
153Likes received
189Likes given
17Badges
69Days visited
923Posts read
Recent activity
Full stream-
Tracking a shortage from primary sources rather than rumour — the long version Replied, post #3 · marked as the solution · Access › Shortages · 27 Jul 2026 · 15 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. Happy to be the one who is wrong here if it settles…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #25 · Analytics › COA interpretation · 25 Jul 2026 · 12 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #8 · Compounds › Repair & healing peptides · 20 Jul 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #96 · Compounds › Semaglutide · 8 Jul 2026 · 0 likes Picking up post #93: that is the part I would want checked first. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #26 · Compounds › Retatrutide · 29 Jun 2026 · 0 likes The arithmetic on retatrutide discussion is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #60 · Evidence › Journal club · 24 Jun 2026 · 3 likes Post #59 answers the question as asked. The question underneath it is different. Source for the SURMOUNT-1 figure, since it was asked for. It is in the discussion…
-
Submitting a sample: the process end to end Replied, post #25 · Sourcing › Independent verification · 19 Jun 2026 · 24 likes Useful. I have added it to my own notes with the date on it.
-
Bioimpedance and hydration: why the number moves Replied, post #58 · Outcomes › Body composition · 10 Jun 2026 · 4 likes Worth separating two things that post #54 runs together. The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated…
-
Racemisation and why it is invisible to a mass measurement Replied, post #15 · Analytics › Impurities & related substances · 9 Jun 2026 · 29 likes Good question, well framed, and I would like to see it answered properly.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #32 · Compounds › Repair & healing peptides · 27 May 2026 · 15 likes Post #31 answers the question as asked. The question underneath it is different. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #19 · Evidence › Trials · 10 May 2026 · 3 likes Coming back to post #17, because the follow-up matters more than the original answer. The figure that circulates in coverage is almost always whichever estimand gives…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #44 · Meta › Announcements · 10 May 2026 · 7 likes Reading rather than contributing, but this is the most useful thread I have found on it.